Altitude Life Science Ventures Side Fund III, L.P.
1 additional placement agent
Every relationship, signal and contact on this record, with the source on each.
Includes 3 days of DFX Intelligence. Then $199/month unless canceled.
What matters now
- 1 LP reportpublic disclosures
1 public LP report name this vehicle; the latest, Alaska Permanent Fund Corporation as of 31 Dec 2025, shows $45M committed.
A named LP and its own performance figures are the strongest outside read on a fund.
FactPublic pension and endowment private-markets disclosures (CalPERS, CalSTRS, WSIB, NYSCRF, Texas TRS, UTIMCO ...)For LPs, fund-of-fundsLimited partners → - +71%reported GAV
Reported gross assets rose from $31M to $53.1M between the Form ADV filings of 31 Mar 2024 and 30 Mar 2026.
The fund's assets as the adviser swears them, never its size or dry powder.
- Vintage
- 2019basis: form d first sale
- Target
- unknownnot announced
- First close
- unknownnever inferred from a Form D
- Final close
- unknownonly from an announcement or an LP disclosure
- Announced size
- unknown
- Form D offering
- $50.0Mwhat may be sold, not what was raised; file 021-331039, sworn by the adviser or filed under this vehicle
- Form D sold
- $50.0Mas of the filing of Jan 22, 2019, 1 investor
- First sale
- Jan 16, 2019
- Reported GAV
- $53.1Mon the Form ADV filed Mar 30, 2026; the fund's assets, never its size or dry powder
- Owners (ADV)
- 2
- Reported on ADV
- Apr 1, 2020 to Mar 30, 2026
LifecycleMature
| Filed | Type | Gross asset value | Owners | Min. investment | Adviser-owned | Audit | |
|---|---|---|---|---|---|---|---|
| Apr 1, 2020 | Venture Capital Fund | $11.5M | 2 | 1% | yes | ||
| Mar 30, 2021 | Venture Capital Fund | $30.5M | 2 | 1% | yes | ||
| Mar 31, 2022 | Venture Capital Fund | $76.5M | 2 | 1% | yes | ||
| Mar 31, 2023 | Venture Capital Fund | $33.7M | 2 | 1% | yes | ||
| Mar 31, 2024 | Venture Capital Fund | $31.0M | 2 | 1% | yes | ||
| Mar 30, 2026 | Venture Capital Fund | $53.1M | 2 | 1% |
- Altitude Ventures Management, LLC Director
- Altitude Life Science Ventures III, LLC Director
- David Maki Director
- AuditorFrank, Rimerman + Co. · SAN FRANCISCO, California, United StatesForm ADV filed Mar 30, 2026 reports.adviserinfo.sec.gov
- AdministratorStandish Management · SEATTLE, Washington, United StatesForm ADV filed Mar 30, 2026 reports.adviserinfo.sec.gov
- CustodianSilicon Valley Bank · SANTA CLARA, California, United StatesForm ADV filed Mar 30, 2026 reports.adviserinfo.sec.gov
| LP | Vintage (LP’s) | Committed | Paid in | Distributed | Remaining value | Net IRR | Multiple | As of |
|---|---|---|---|---|---|---|---|---|
| Alaska Permanent Fund Corporation apfc.org | 2019 | $45.0M | Not disclosed | Not disclosed | Not disclosed | not meaningful yet | unknown | Dec 31, 2025 |
| Allocator | Type | Amount | Date | Source |
|---|---|---|---|---|
| Alaska Permanent Fund Corporation | SOVEREIGN LINKED US ALLOCATOR | $45.0M committed | reported as of Dec 31, 2025 | Fact Pension disclosure |
- Dec 31, 2025APFC reports Altitude Life Science Ventures Side Fund III LP: $45,000,000 committed, vintage 2019LP commitment disclosed Fact Pension disclosure
- Apr 1, 2020Altitude Life Science Ventures Side Fund III, L.P. first reported on Form ADV by Altitude Ventures Management, LLC (Venture Capital Fund), GAV $11,501,190Fund first reported on Form ADV Fact Form ADV
- Jan 22, 2019Altitude Life Science Ventures Side Fund III, L.P. filed Form D: $50,000,000 sold of $50,000,000, Venture Capital FundForm D filed Fact Form D
Every observation on this vehicle
- Entity type: Limited Partnership Fact Form D
- Entity type: Limited Partnership Jan 22, 2019 Fact Form D
- Form D fund type: Venture Capital Fund Fact Form D
- Form D fund type: Venture Capital Fund Jan 22, 2019 Fact Form D
- Form D industry group: Pooled Investment Fund Fact Form D
- Form D industry group: Pooled Investment Fund Jan 22, 2019 Fact Form D
- Amendment: false Fact Form D
- Amendment: false Jan 22, 2019 Fact Form D
- Revenue range (Form D): Decline to Disclose Fact Form D
- Revenue range (Form D): Decline to Disclose Jan 22, 2019 Fact Form D
- Incorporated: withinFiveYears Fact Form D
- Incorporated: withinFiveYears Jan 22, 2019 Fact Form D
- Jurisdiction: Delaware Fact Form D
- Jurisdiction: Delaware Jan 22, 2019 Fact Form D
- Amount sold (Form D): $50.0M Fact Form D
- Amount sold (Form D): $50.0M Jan 22, 2019 Fact Form D
- Offering amount (Form D): $50.0M Fact Form D
- Offering amount (Form D): $50.0M Jan 22, 2019 Fact Form D
- Exemptions: 06b, 3C, 3C.1, 3C.7 Fact Form D
- Exemptions: 06b, 3C, 3C.1, 3C.7 Jan 22, 2019 Fact Form D
- First sale: 2019-01-16 Fact Form D
- First sale: 2019-01-16 Jan 22, 2019 Fact Form D
- Investors (Form D): 1 Fact Form D
- Investors (Form D): 1 Jan 22, 2019 Fact Form D
- Minimum investment (Form D): 0 Fact Form D
- Minimum investment (Form D): 0 Jan 22, 2019 Fact Form D
- Securities offered: pooled Fact Form D
- Securities offered: pooled Jan 22, 2019 Fact Form D
- Office address: Fact Form D
- Office address: Jan 22, 2019 Fact Form D
- Year of incorporation: 2019 Fact Form D
- Year of incorporation: 2019 Jan 22, 2019 Fact Form D
Relationships across DFX
on 2 other DFX graphs
Altitude Life Science Ventures Side Fund III, L.P. is the same institution as 2 records in Allocators and RIA and Wealth.
DFX found 2 relationships across 2 datasets
Which record it is in each graph, what it is called there, and how the two were matched.
Includes 3 days of DFX Intelligence. Then $199/month unless canceled.
Checking your plan…
Record history
- LP commitment disclosed2025-12-31source on record
- Fund first reported on ADV2020-04-01source on record
- Form D filed2019-01-22source on record
The ledger records every merge, rename and reclassification this record went through and the dated filings observed on it, so the identity on this page can be traced to the records it was built from. The ledger's own sentences name other records, so they show with the names.